Kishan Bhalodia
About Kishan Bhalodia
Kishan Bhalodia is the Senior Manager of Global ICSR Management at BeiGene, with extensive experience in drug safety and clinical research management.
Company
Kishan Bhalodia is currently employed at BeiGene, a global biotechnology company specializing in the development of innovative cancer therapies. He serves as the Senior Manager of Global Individual Case Safety Reports (ICSR) Management. BeiGene is recognized for its work in oncology and delivering new, cutting-edge treatments for cancer patients worldwide.
Title
Kishan Bhalodia holds the title of Senior Manager, Global ICSR Management at BeiGene. His role involves extensive oversight and management of Individual Case Safety Reports, ensuring compliance with international regulatory standards and contributing to the safety profiling of oncology products.
Education and Expertise
Kishan Bhalodia has a strong academic background with a Master's degree in Clinical Research and Pharmacovigilance, obtained from 2009 to 2011. He also holds a Bachelor of Pharmacy degree, achieved from 2005 to 2009. His expertise lies in managing drug safety operations, particularly in oncology, and he possesses a deep understanding of FDA regulations and compliance.
Professional Background
Kishan Bhalodia has accrued substantial experience in drug safety and clinical research over the years. At BeiGene, he previously worked as Manager of Drug Safety Operations. His career also includes roles such as Team Lead - Senior Drug Safety Specialist at Impax Laboratories, Senior Specialist in Drug Safety at Consultant, Drug Safety Associate III at Jazz Pharmaceuticals, and Clinical Safety Associate II at Genentech. He began his career as a Drug Safety Specialist at GVK BIO.
Global ICSR Management Experience
Kishan Bhalodia has a notable track record in managing Individual Case Safety Reports (ICSRs) on a global scale. His expertise in this area is derived from his extensive experience in various roles and companies, where he has ensured adherence to safety and compliance standards, particularly in drug safety operations for oncology products. His role demands a comprehensive understanding of global regulatory requirements and best practices in pharmacovigilance.